Safety and Efficacy of Tianfoshen Oral Liquid in Non-Small Cell Lung Cancer Patients as an Adjuvant Therapy

Table 1

Demographic and baseline characteristics of patients.

Characteristics	Total
	No.	%
Age (years)	56 (30-75)
Gender
Male	76	70.37
Female	32	29.63
Pathological diagnosis
Adenocarcinoma	79	73.15
Squamous	23	21.3
adenosquamous	6	5.55
TMN staging
IIIA	22	20.37
IIIB	26	24.07
IV	60	55.56
Metastatic disease
Any	75	69.44
Lung^1	32	29.63
Liver^1	6	5.56
Lymph^1	22	20.37
ECOG PS
0	12	11.11
1	82	75.93
2	14	12.96

Percentages are based on total number of patients with metastatic disease.